There is an increasingly impressive database concerning the possible involv
ement of cytokines in depression and their role in the therapeutic effects
of antidepressants. Based on the discussions which took place on these issu
es at a recent meeting held in Roscoff, France, this perspective summarizes
in a critical way the evidence in favor of such a possibility, and points
out the needs for further research to clarify both the nature of the subtle
dysregulations that affect neuroendocrine-immune interactions in depressiv
e disorders and their contribution to psychopathology.